Drawing for XERO

USPTO serial 88398578

XERO

Reviewed by CopyMark Law Group

Reg. 6005553Status 702Registered
Filing date
Status date
Registration date
Mar 10, 2020
Examiner
FOSS, KATHERINE M
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with XERO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Theodore A. Breiner

Theodore A. Breiner BREINER & BREINER, L.L.C.115 North Henry StreetAlexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software providing for a workflow centric platform that enhances and speeds up medical-diagnostic image and medical-diagnostic data acquisition and retrieval, optimizes system efficiency and performance and allows collaboration across departments, hospitals or regions; downloadable computer software providing for a unified imaging platform providing picture archiving and communication systems (PACS and Enterprise Imaging), reporting, advanced medical-diagnostic image processing, integration of clinical information, results distribution and analytics of medical-diagnostic images and medical-diagnostic data; downloadable web-based software providing secure access to medical-diagnostic images and reports from different departments and multiple sources within a healthcare environmentACTIVE—
042Software as a Service (SaaS), namely providing others with computer software for providing a workflow centric platform that enhances and speeds up medical-diagnostic images and medical-diagnostic data acquisition and retrieval, optimizes system efficiency and performance and allows collaboration across departments, hospitals or regions; software as a Service (SaaS), namely providing others with a unified imaging platform providing picture archiving and communication systems (PACS and Enterprise Imaging), reporting, advanced medical-diagnostic image processing, integration of clinical information, results distribution and analytics of medical-diagnostic images and medical-diagnostic data; software as a Service (SaaS), namely providing others with temporary use of non-downloadable web-based software providing secure access to medical-diagnostic images and reports from different departments and multiple sources within a healthcare environmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 12, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 12, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 12, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 18, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Mar 10, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 10, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2019ALIEASSIGNED TO LIE—
Nov 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2019DOCKASSIGNED TO EXAMINER—
May 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 26, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance